JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
Management of Venous Thromboembolism for Patients with Hematologic Malignancies
What are the main risk factors for VTE in cancer patients?
Rowena Schwartz, PharmD, BCOP
University of Cincinnati
What do NCCN guidelines say about anticoagulants and when they should be used?
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.